CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 85 enrolled
Drug / intervention
Probiotics (Lactobacillus rhamnosus GG (ATCC 53103)dietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06464484
NCT06464484N/ACompleted
CompareCT.gov

The Effects Of Probiotics On Stress And Bowel Habits Among Healthy Adults From Umm Al-Qura University at Makkah: A Randomized Interventional Study

Umm Al-Qura University·interventional·Posted Jun 18, 2024·Updated Jun 20, 2024

In Brief

A clinical study evaluating Probiotics (Lactobacillus rhamnosus GG (ATCC 53103) for Stress and 3 related conditions. Completed, enrolled 85 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to study the effects of probiotic supplementation on stress levels and bowel habits in healthy Saudi adults for both males and females. The main questions it aims to answer are: Does probiotic supplementation decrease stress levels? Does probiotic supplementation improve bowel habits? Researchers compared between the intervention group receiving probiotic supplements with high stress levels with a control group not receiving probiotics with high stress levels to see if probiotics decreases stress levels.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStress, Constipation, Anthropometry, Bowel Disease
CountriesSaudi Arabia
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 18, 2024
Enrollment StartJan 26, 2023
Primary CompletionMar 31, 2024
Study CompletionApr 30, 2024
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 2.0 years ago

Interventions

Probiotics (Lactobacillus rhamnosus GG (ATCC 53103)dietary

Already mentioned in arm/group descriptions